Columbia River Oncology Program is a clinical research site located in Portland, Oregon, United States 97225.
Crixeo Health Trust Score: 75/100 (FAIR). This profile has not yet been claimed by the site owner.
Columbia River Oncology Program has participated in 7 clinical trials.
Therapeutic areas: Breast Cancer, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7).
Sponsors: NSABP Foundation Inc, ECOG-ACRIN Cancer Research Group, Canadian Cancer Trials Group.
Trust Score: 75/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Columbia River Oncology Program has a Crixeo Trust Score of 75/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Columbia River Oncology Program has 7 clinical trials on record. Their work covers Breast Cancer, Acute Myeloid Leukemia With Multilineage Dysplasia Following Myelodysplastic Syndrome, Adult Acute Megakaryoblastic Leukemia (M7).
Yes — Columbia River Oncology Program holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.